Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)
Clinical calculations and diagnostic scoring systems like FeverPAIN Score frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.
What is the FeverPAIN Score?
The FeverPAIN Score is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in infectious disease practice. The FeverPAIN Score is a newer clinical decision rule from the UK (NICE guidelines) designed to predict the likelihood of Group A streptococcal pharyngitis and identify those most likely to benefit from antibiotics. Clinical scoring tools like FeverPAIN Score are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).
💡Clinical Pearls & Diagnostic Utility
Provides a modern alternative to the Centor/McIsaac scores, explicitly capturing severity of inflammation and symptom duration.
Formula & Calculation Parameters
The mathematical equation and clinical variables required to calculate FeverPAIN Score:
Score Interpretation & Clinical Stratification
| Score Range | Clinical Interpretation | Risk Tier |
|---|---|---|
| ≤ 1 | Low Risk | green |
| 2 – 3 | Moderate Risk | yellow |
| ≥ 4 | High Risk | red |
When to Exercise Caution
Validation primarily performed in UK primary care settings. May be less predictive in populations with high background rates of Strep carriage.
Clinical Review Board
Dr. Muhammad Nouman, MBBS
Capital Medical University | PMDC Reg No: 117744-P
Clinical Audit Status
✓ Verified for 2026 Guidelines
Last updated: 2026-08-07
Peer-Reviewed Medical Literature
- •Little P, Moore M, Hobbs FD, et al. PRImary care Streptococcal Management (PRISM) study: identifying clinical variables associated with Lancefield group A beta-haemolytic streptococci and Lancefield non-Group A streptococci from patients with acute sore throat. BMJ Open. 2013;3(10):e003943.
Related Infectious Disease Calculators & Scoring Tools
Explore related clinical calculators, risk stratification indexes, and diagnostic scoring algorithms in Infectious Disease:
HbA1c to Estimated Average Glucose (eAG)
Converts HbA1c percentage to an average daily blood glucose level.
Absolute Lymphocyte Count (ALC)
Calculates the true number of lymphocytes in the blood.
Estimated Due Date (EDD)
Calculates the Estimated Due Date (EDD) using Naegele's rule.
McIsaac Score (Modified Centor)
Estimates the probability of Group A Streptococcal pharyngitis.
Pneumonia Severity Index (PSI/PORT)
Estimates mortality for Community-Acquired Pneumonia (CAP).
ASCVD Risk Estimator (10-Year)
Calculates the 10-year risk of heart disease and stroke.